Skip to main content
. Author manuscript; available in PMC: 2009 Apr 1.
Published in final edited form as: J Oral Maxillofac Surg. 2008 Apr;66(4):625–631. doi: 10.1016/j.joms.2007.11.032

Table 4.

Comorbidities and risk of ONJ.

Crude Adjusted

Comorbidities Odds Ratio 95% C.I Odds Ratio 95% C.I

Alcohol Abuse 3.75 0.84 – 16.76 0.13 0.00 – 10.22
Asthma 1.73 0.60 – 5.00 1.17 0.18 – 7.55
Deep Vein Thrombosis 2.14 0.55 – 8.29 0.33 0.02 – 6.66
Diabetes 2.26 0.88 – 5.84 1.68 0.40 – 6.99
Gastric Reflux 0.94 0.39 – 2.25 0.92 0.17 – 4.97
Hypercholesterolemia 1.32 0.54 – 3.23 1.50 0.33 – 6.83
Hypertension 1.74 0.74 – 4.08 1.17 0.31 – 4.37
Obesity 4.02* 1.79 – 9.03 16.61* 1.80 – 153.71
Osteoporosis 0.70 0.21 – 2.35 2.26 0.29 – 17.65
Smoking: yes 5.94* 2.28 – 15.49 7.41* 1.28 – 43.10
 per pack year 1.04* 1.01 – 1.06 1.03 0.97 – 1.10
Metastasis 41.09* 5.35 – 315.38 27.39* 0.99 – 757.40
*

p<0.05

adjusted for metastasis, zoledronate, obesity, and smoking